Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEvogene Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.97 | -$0.93 | -$0.95 |
| Q2 2024 | 1 | -$1.28 | -$1.22 | -$1.25 |
| Q3 2024 | 1 | -$1.03 | -$0.99 | -$1.01 |
| Q4 2024 | 2 | -$0.76 | -$0.69 | -$0.73 |
| Q1 2025 | 1 | -$0.75 | -$0.71 | -$0.73 |
| Q2 2025 | 1 | -$0.90 | -$0.86 | -$0.88 |
| Q3 2025 | 1 | -$0.81 | -$0.77 | -$0.79 |
| Q4 2025 | 1 | -$0.63 | -$0.61 | -$0.62 |
Evogene Ltd. Earnings Date And Information
Evogene Ltd. last posted its earnings results on Thursday, November 21st, 2024. The company reported $-1.31 earnings per share for the quarter, missing analysts' consensus estimates of $-1.01 by $0.3. The company had revenue of 1.80 M for the quarter and had revenue of 5.64 M for the year. Evogene Ltd. has generated $-5 earnings per share over the last year ($-5.23 diluted earnings per share) and currently has a price-to-earnings ratio of -3.32. Evogene Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based on prior year's report dates.
Evogene Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/21/2024 | Q3 2024 | -$1.01 | -$1.31 | -0.3 | $2.85 M | $1.80 M |
| 09/16/2024 | Q2 2024 | -$1.06 | $775,000 | $914,000 | ||
| 03/30/2024 | Q1 2024 | -$0.76 | $4.19 M | |||
| 03/28/2024 | Q4 2023 | -$1.30 | $578,000 | |||
| 09/29/2023 | Q3 2023 | -$0.81 | $1.20 M | $3.77 M | ||
| 06/30/2023 | Q2 2023 | -$16.78 | $885,000 | $654,000 | ||
| 03/31/2023 | Q1 2023 | -$1.51 | $641,000 | |||
| 03/30/2023 | Q4 2022 | -$0.07 | $660,000 | |||
| 09/29/2022 | Q3 2022 | -$0.16 | $234,667 | $466,000 | ||
| 06/29/2022 | Q2 2022 | -$0.24 | $230,667 | $312,000 | ||
| 03/30/2022 | Q1 2022 | -$0.22 | $237,000 | |||
| 03/31/2022 | Q4 2021 | -$0.18 | $311,000 | |||
| 09/29/2021 | Q3 2021 | -$0.19 | $112,000 | $151,000 | ||
| 06/29/2021 | Q2 2021 | -$0.15 | $218,000 | $135,000 | ||
| 03/30/2021 | Q1 2021 | -$0.17 | $333,000 | |||
| 04/02/2021 | Q4 2020 | -$0.24 | $351,000 | |||
| 09/29/2020 | Q3 2020 | -$0.18 | $316,000 | |||
| 08/05/2020 | Q2 2020 | -$0.16 | $298,000 | |||
| 04/27/2020 | Q1 2020 | -$0.24 | $75,000 | |||
| 04/27/2020 | Q4 2019 | -$0.24 | $116,000 |
Evogene Ltd. Earnings: FAQ's
When is Evogene Ltd.'s earnings date?
Evogene Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates.
How can I listen to Evogene Ltd.'s earnings conference
call?
The conference call for Evogene Ltd.'s latest earnings report can be listened to online.
How can I read Evogene Ltd.'s conference call transcript?
The conference call transcript for Evogene Ltd.'s latest earnings report can be read online.
How much revenue does Evogene Ltd. generate each year?
Evogene Ltd. (:EVGN) has a recorded annual revenue of $5.64 M.
How much profit does Evogene Ltd. generate each year?
Evogene Ltd. (:EVGN) has a recorded net income of $5.64 M. Evogene Ltd. has generated $-5.23 earnings per share over the last four quarters.
What is Evogene Ltd.'s price-to-earnings ratio?
Evogene Ltd. (:EVGN) has a price-to-earnings ratio of -3.32 and price/earnings-to-growth ratio is -0.17.